delete

Breast Cancer Breakthrough

Recently, researchers at Lawrence Berkeley National Laboratory have developed the first clinically-relevant mouse model of human breast cancer, as part of successfully expressing functional estrogen receptor positive (ER+) adenocarcinomas.  The tumors that have been generated in this system bear a strong resemblance to the class of tumors that can be found among most women with breast cancer, in particular those whose cancer proves treatment-resistant.  Such a model could prove itself a powerful tool for testing therapies for aggressive E+ breast cancers, as well as for...